<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02369393</url>
  </required_header>
  <id_info>
    <org_study_id>UJaimeI06</org_study_id>
    <nct_id>NCT02369393</nct_id>
  </id_info>
  <brief_title>Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity</brief_title>
  <acronym>PROMETEOII</acronym>
  <official_title>Treatment of Depression: Efficacy and Efficiency of Two Self-administered Online Intervention Protocols Based on Behavioral Activation and Physical Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Jaume I</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitat Politècnica de València</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitat Jaume I</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the clinical and cost-effectiveness of Behavioral Activation (BA) and Physical
      Activity (PA) for adults with major depressive disorder (MDD) or adjustment disorder with
      depressive symptomatology with a wait list control group (WL) in Spanish population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research shows that in 2030 (Mathers and Loncar, 2006) depression will become one of the
      three leading causes of disability. Depression is a common mental disorder with a negative
      impact on mental well-being, quality of life, and social and work-related functioning both in
      the short and longer term.

      Additionally, depression is associated with increased morbidity, mortality, health care
      utilization and health care costs. On a population level, depression is one of the most
      costly diseases. The economic costs of depression were estimated at €136.3 billion (EU25) in
      2010 in the EU and are still rising. European health care systems face the challenge of
      improving access to cost-effective treatments while simultaneously working to sustain
      budgetary stability in times of economic austerity.

      Internet-based depression treatment appears a very promising alternative to current routine
      depression treatment strategies. Meta-analyses have demonstrated the clinical effectiveness
      and potential cost-effectiveness of Internet-based treatment for depression in controlled
      research setting. Internet-based treatment thus has the potential to keep depression
      treatment affordable, as it enables mental health care providers to reach out to large
      populations needing depression treatment at a better cost-effectiveness, but with similar
      levels of clinical efficacy and quality of care.

      In Spain the trial will be carried out in a community sample, comparing the clinical and
      cost-effectiveness of BA or PA with WL for adults with major depressive disorder (MDD) and
      adjustment disorder with depressive symptomatology. Respondents will be followed until 6
      months after baseline (measures will be taken at BL, 3 months, and 6 months).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Patient Health Questionnaire-9</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Beck Depression Inventory</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the EQ-5D-5L (EuroQol)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Quality of Life (QLI)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Overall Anxiety Severity and Impairment Scale (OASIS)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Positive and Negative Affect Scale (PANAS)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Happiness Scale (Fordyce)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Satisfaction with Life Scale (SWLS, Diener)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Ryff Scale of Psychological Wellbeing</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Behavioral Activation for Depression Scale - Short Form (BADS-SF)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Environmental Reward Observation Scale (EROS)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Beck Depression Inventory (BDI-II)</measure>
    <time_frame>Change from baseline to 2 months, 5 months, and 8 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Eysenck Personality Questionnaire-Revised Short Form (Neuroticism subscale)</measure>
    <time_frame>Baseline</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Credibility and expectancy questionnaire (CEQ)</measure>
    <time_frame>2 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Self concordance motivation (SCM)</measure>
    <time_frame>2 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Working Alliance Inventory (WAI-SF)</measure>
    <time_frame>3 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>System usability scale (SUS)</measure>
    <time_frame>2 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in preferences for treatment scale (self-applied vs face to face)</measure>
    <time_frame>Change from baseline to 2 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction with the treatment</measure>
    <time_frame>2 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in the MINI International Neuropsychiatric Interview (M.I.N.I) version 5.0</measure>
    <time_frame>Change from baseline to 2 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in Structured Clinical Interview (SCID-I) for Adjustment Disorders</measure>
    <time_frame>Change from baseline to 2 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Attitudes towards Psychological Online Interventions Questionnaire (APOI)</measure>
    <time_frame>Baseline</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Semi-structured interview about users´ intervention experience</measure>
    <time_frame>2 months</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Behavioral Activation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BA treatment for depression is a simple, cost-effective method. There is evidence that the behavioral component may be the active mechanism of change in cognitive-behavioral treatments of clinical depression. One of the main objectives of the treatment is to systematically increase exposure to positive activities, and thereby improve affect and corresponding cognitions. Treatment will be delivered through an Internet based treatment platform with mobile phone components (either integrated in the treatment platform or as a separate system). The core components are: 1) psycho-education, 2) identifying important values and significant activities, 3) activity structuring and scheduling, 4) relapse prevention. These will be delivered over 4 modules. There will be a minimal therapist support.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting list control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the waiting list control group (WL), subjects will receive no treatment during 8 weeks. We will not interfere but we will monitor carefully through self-report. Then participants will be randomised to the two treatment groups.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Activity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There is evidence to suggest that the addition of cognitive behavioral therapies, specifically exercise, can improve treatment outcomes for many patients. Exercise is a behavioral intervention that has shown great promise in alleviating symptoms of depression. The treatment will be delivered through an Internet based treatment platform with mobile phone components (either integrated in the treatment platform or as a separate system). The core components of the PA treatment are: 1) psychoeducation: understand the mental health benefits of physical activity, 2) learn about the types and amounts of physical activity recommended, 3) motivation to perform and maintain physical activities, 4) relapse prevention. These will be delivered over 4 modules. There will be a minimal therapist support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Activation</intervention_name>
    <description>Behavioral Activation intervention promotes the involvement in meaningful activities close to personal values.</description>
    <arm_group_label>Behavioral Activation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Activity</intervention_name>
    <description>Physical Activity intervention promotes the gradual increase of the frequency and intensity of PA levels, with special attention to motivational strategies.</description>
    <arm_group_label>Physical Activity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being 18 years of age or older

          -  Meet DSM-IV diagnostic criteria for MDD and adjustment disorder confirmed by MINI
             International Neuropsychiatric Interview version 5.0 and SCID I

          -  A score of 5 or higher on the PHQ-9 screening questionnaire.

        Exclusion Criteria:

          -  Current high risk for suicide according to the MINI Interview section C

          -  Serious psychiatric co-morbidity: substance dependence, bipolar affective disorder,
             psychotic illness, obsessive compulsive disorder, as established at the MINI interview

          -  Currently receiving psychological treatment for depression in primary or specialised
             mental health care

          -  Being unable to comprehend the spoken and written language (Spanish)

          -  Not having access to a PC and fast Internet connection (i.e. broadband or comparable).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cristina Botella, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat Jaume I;CIBERObn ISC III, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rosa Baños, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat de Valencia; CIBERObn ISC III, Spain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristina Botella, PhD</last_name>
    <phone>+34 964 38 76 39</phone>
    <phone_ext>7639</phone_ext>
    <email>botella@uji.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guadalupe Molinari, MA</last_name>
    <phone>+34 964 38 76 45</phone>
    <email>guadalupemolinari@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Jaume I</name>
      <address>
        <city>Castelló de la Plana</city>
        <zip>12071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Botella Arbona, PhD</last_name>
      <phone>+34 964 38 76 39</phone>
      <phone_ext>76 39</phone_ext>
      <email>botella@uji.es</email>
    </contact>
    <contact_backup>
      <last_name>Guadalupe Molinari, MA</last_name>
      <phone>+34 964 38 76 45</phone>
      <phone_ext>76 45</phone_ext>
      <email>guadalupemolinari@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Cristina Botella Arbona, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosa Baños Rivera, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Macarena Espinoza, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guadalupe Molinari, MA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196-205. doi: 10.1080/16506070903318960.</citation>
    <PMID>20183695</PMID>
  </reference>
  <reference>
    <citation>Cavanagh K, Shapiro DA. Computer treatment for common mental health problems. J Clin Psychol. 2004 Mar;60(3):239-51. Review.</citation>
    <PMID>14981789</PMID>
  </reference>
  <reference>
    <citation>Coffman SJ, Martell CR, Dimidjian S, Gallop R, Hollon SD. Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? J Consult Clin Psychol. 2007 Aug;75(4):531-41.</citation>
    <PMID>17663608</PMID>
  </reference>
  <reference>
    <citation>Davidson TM, Yuen EK, Felton JW, McCauley J, Gros KS, Ruggiero KJ. Feasibility assessment of a brief, web-based behavioral activation intervention for adolescents with depressed mood. Int J Psychiatry Med. 2014;48(1):69-82. doi: 10.2190/PM.48.1.f.</citation>
    <PMID>25354927</PMID>
  </reference>
  <reference>
    <citation>Sudak DM, Majeed MH, Youngman B. Behavioral activation: a strategy to enhance treatment response. J Psychiatr Pract. 2014 Jul;20(4):269-75. doi: 10.1097/01.pra.0000452563.05911.c9.</citation>
    <PMID>25036582</PMID>
  </reference>
  <reference>
    <citation>Cuijpers P, Donker T, van Straten A, Li J, Andersson G. Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies. Psychol Med. 2010 Dec;40(12):1943-57. doi: 10.1017/S0033291710000772. Epub 2010 Apr 21. Review.</citation>
    <PMID>20406528</PMID>
  </reference>
  <reference>
    <citation>Soucy Chartier I, Provencher MD. Behavioural activation for depression: efficacy, effectiveness and dissemination. J Affect Disord. 2013 Mar 5;145(3):292-9. doi: 10.1016/j.jad.2012.07.023. Epub 2012 Aug 9. Review.</citation>
    <PMID>22884236</PMID>
  </reference>
  <reference>
    <citation>Churchill R, Moore TH, Furukawa TA, Caldwell DM, Davies P, Jones H, Shinohara K, Imai H, Lewis G, Hunot V. 'Third wave' cognitive and behavioural therapies versus treatment as usual for depression. Cochrane Database Syst Rev. 2013 Oct 18;(10):CD008705. doi: 10.1002/14651858.CD008705.pub2. Review.</citation>
    <PMID>24142810</PMID>
  </reference>
  <reference>
    <citation>Dimidjian S, Barrera M Jr, Martell C, Muñoz RF, Lewinsohn PM. The origins and current status of behavioral activation treatments for depression. Annu Rev Clin Psychol. 2011;7:1-38. doi: 10.1146/annurev-clinpsy-032210-104535. Review.</citation>
    <PMID>21275642</PMID>
  </reference>
  <reference>
    <citation>Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, Atkins DC, Dunner DL, Jacobson NS. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006 Aug;74(4):658-70.</citation>
    <PMID>16881773</PMID>
  </reference>
  <reference>
    <citation>Fitzsimons CF, Baker G, Gray SR, Nimmo MA, Mutrie N; Scottish Physical Activity Research Collaboration (SPARColl). Does physical activity counselling enhance the effects of a pedometer-based intervention over the long-term: 12-month findings from the Walking for Wellbeing in the west study. BMC Public Health. 2012 Mar 19;12:206. doi: 10.1186/1471-2458-12-206.</citation>
    <PMID>22429600</PMID>
  </reference>
  <reference>
    <citation>Azevedo Da Silva M, Singh-Manoux A, Brunner EJ, Kaffashian S, Shipley MJ, Kivimäki M, Nabi H. Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study. Eur J Epidemiol. 2012 Jul;27(7):537-46. doi: 10.1007/s10654-012-9692-8. Epub 2012 May 24.</citation>
    <PMID>22623145</PMID>
  </reference>
  <reference>
    <citation>Loprinzi PD, Mahoney S. Concurrent occurrence of multiple positive lifestyle behaviors and depression among adults in the United States. J Affect Disord. 2014 Aug;165:126-30. doi: 10.1016/j.jad.2014.04.073. Epub 2014 May 5.</citation>
    <PMID>24882189</PMID>
  </reference>
  <reference>
    <citation>Goodwin RD. Association between physical activity and mental disorders among adults in the United States. Prev Med. 2003 Jun;36(6):698-703.</citation>
    <PMID>12744913</PMID>
  </reference>
  <reference>
    <citation>Harvey SB, Hotopf M, Overland S, Mykletun A. Physical activity and common mental disorders. Br J Psychiatry. 2010 Nov;197(5):357-64. doi: 10.1192/bjp.bp.109.075176.</citation>
    <PMID>21037212</PMID>
  </reference>
  <reference>
    <citation>Hollon SD, Ponniah K. A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety. 2010 Oct;27(10):891-932. doi: 10.1002/da.20741. Review.</citation>
    <PMID>20830696</PMID>
  </reference>
  <reference>
    <citation>Jancey JM, Lee AH, Howat PA, Clarke A, Wang K, Shilton T. The effectiveness of a physical activity intervention for seniors. Am J Health Promot. 2008 May-Jun;22(5):318-21. doi: 10.4278/ajhp.22.5.318.</citation>
    <PMID>18517091</PMID>
  </reference>
  <reference>
    <citation>Johansson R, Andersson G. Internet-based psychological treatments for depression. Expert Rev Neurother. 2012 Jul;12(7):861-9; quiz 870. doi: 10.1586/ern.12.63. Review.</citation>
    <PMID>22853793</PMID>
  </reference>
  <reference>
    <citation>King AC, Friedman R, Marcus B, Castro C, Napolitano M, Ahn D, Baker L. Ongoing physical activity advice by humans versus computers: the Community Health Advice by Telephone (CHAT) trial. Health Psychol. 2007 Nov;26(6):718-27.</citation>
    <PMID>18020844</PMID>
  </reference>
  <reference>
    <citation>Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif. 2011 Mar;35(2):111-61. doi: 10.1177/0145445510390929.</citation>
    <PMID>21324944</PMID>
  </reference>
  <reference>
    <citation>Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004366. doi: 10.1002/14651858.CD004366.pub4. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD004366.</citation>
    <PMID>19588354</PMID>
  </reference>
  <reference>
    <citation>Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009 Feb;36(2):165-73. doi: 10.1016/j.amepre.2008.09.040. Review.</citation>
    <PMID>19135907</PMID>
  </reference>
  <reference>
    <citation>Mota-Pereira J, Silverio J, Carvalho S, Ribeiro JC, Fonte D, Ramos J. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder. J Psychiatr Res. 2011 Aug;45(8):1005-11. doi: 10.1016/j.jpsychires.2011.02.005. Epub 2011 Mar 5.</citation>
    <PMID>21377690</PMID>
  </reference>
  <reference>
    <citation>Pinninti NR, Madison H, Musser E, Rissmiller D. MINI International Neuropsychiatric Schedule: clinical utility and patient acceptance. Eur Psychiatry. 2003 Nov;18(7):361-4.</citation>
    <PMID>14643565</PMID>
  </reference>
  <reference>
    <citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.</citation>
    <PMID>11556941</PMID>
  </reference>
  <reference>
    <citation>König HH, Born A, Günther O, Matschinger H, Heinrich S, Riedel-Heller SG, Angermeyer MC, Roick C. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health Qual Life Outcomes. 2010 May 5;8:47. doi: 10.1186/1477-7525-8-47.</citation>
    <PMID>20444251</PMID>
  </reference>
  <reference>
    <citation>Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011 Feb;31(1):89-103. doi: 10.1016/j.cpr.2010.09.008. Epub 2010 Oct 14. Review.</citation>
    <PMID>21130939</PMID>
  </reference>
  <reference>
    <citation>Plonczynski DJ. Measurement of motivation for exercise. Health Educ Res. 2000 Dec;15(6):695-705. Review.</citation>
    <PMID>11142077</PMID>
  </reference>
  <reference>
    <citation>Stanton R, Reaburn P. Exercise and the treatment of depression: a review of the exercise program variables. J Sci Med Sport. 2014 Mar;17(2):177-82. doi: 10.1016/j.jsams.2013.03.010. Epub 2013 Apr 18. Review.</citation>
    <PMID>23602562</PMID>
  </reference>
  <reference>
    <citation>Mammen G, Faulkner G. Physical activity and the prevention of depression: a systematic review of prospective studies. Am J Prev Med. 2013 Nov;45(5):649-57. doi: 10.1016/j.amepre.2013.08.001. Review.</citation>
    <PMID>24139780</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2015</study_first_submitted>
  <study_first_submitted_qc>February 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2015</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Internet based treatment</keyword>
  <keyword>Depression</keyword>
  <keyword>Efficacy</keyword>
  <keyword>Cost-effectiveness</keyword>
  <keyword>Behavioral Activation</keyword>
  <keyword>Self-applied</keyword>
  <keyword>Ecological Momentary Assessment</keyword>
  <keyword>Physical Activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

